A detailed history of Colony Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Colony Group LLC holds 10,175 shares of BSX stock, worth $920,532. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,175
Previous 10,309 1.3%
Holding current value
$920,532
Previous $558,000 3.76%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $6,725 - $7,327
-134 Reduced 1.3%
10,175 $537,000
Q2 2023

Aug 15, 2023

SELL
$49.72 - $54.64 $32,566 - $35,789
-655 Reduced 5.97%
10,309 $558,000
Q1 2023

May 16, 2023

SELL
$45.09 - $50.03 $405,855 - $450,320
-9,001 Reduced 45.08%
10,964 $549,000
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $417,239 - $498,029
10,547 Added 111.99%
19,965 $924,000
Q3 2022

Nov 15, 2022

SELL
$36.71 - $109.66 $3,083 - $9,211
-84 Reduced 0.88%
9,418 $365,000
Q2 2022

Aug 16, 2022

BUY
$35.24 - $47.1 $2,960 - $3,956
84 Added 0.89%
9,502 $354,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $124,540 - $137,329
3,045 Added 47.78%
9,418 $417,000
Q4 2021

Feb 15, 2022

BUY
$38.07 - $44.87 $26,649 - $31,409
700 Added 12.34%
6,373 $271,000
Q2 2021

Aug 18, 2021

SELL
$38.58 - $44.24 $1,851 - $2,123
-48 Reduced 0.84%
5,673 $243,000
Q1 2021

May 21, 2021

BUY
$35.27 - $39.67 $201,779 - $226,952
5,721 New
5,721 $221,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $232,978 - $294,965
-7,028 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$34.44 - $42.23 $6,199 - $7,601
-180 Reduced 2.5%
7,028 $269,000
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $217,609 - $281,904
7,208 New
7,208 $253,000
Q1 2020

May 18, 2020

SELL
$25.83 - $45.71 $193,647 - $342,687
-7,497 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$37.87 - $45.37 $283,911 - $340,138
7,497 New
7,497 $339,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.